10 independently detected trends connected to this subject, with the latest coverage first.
This hub groups 10 separate news trends connected to Gene Therapy, spanning June 22, 2026 through August 28, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 73 article observations and 72 source signals, led by Business, Health, Science coverage. Use it to compare how individual events emerged, spread and changed over time.
A single-time gene therapy treatment has shown sustained cholesterol reduction for a year, sparking investor interest and medical hope.
A new lipid nanoparticle promises to extend the duration of gene expression, potentially revolutionizing RNA therapies.
A third death in China's gene therapy trials raises questions about the safety and oversight of these experimental treatments.
A child's death in China raises questions about the ethics of gene therapy.
8 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
Three major institutions have launched the Center for Therapeutic Genetics to develop medicines for rare and ultra-rare genetic diseases.
MeiraGTx has secured significant new funding from Oberland Capital to advance two gene therapies toward commercialization.
The FDA's top gene therapy regulator is stepping down, amid a significant setback for a kidney disease drug.
A Louisiana man is the first in the state to be functionally cured of sickle cell disease.
The FDA is reversing its rejection of Regenxbio's gene therapy for Hunter syndrome, marking the third such reversal for rare-disease drugs.